Prostate imaging drug Pylarify has become the first radiodiagnostic blockbuster, achieving over $1 billion in sales for 2024. The addressable market continues to expand. Where to invest $1,000 ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

Pylarify reached $1 billion in 2024 sales with 15.7% growth in the fourth quarter. The company announced two strategic acquisitions to expand diagnostic and therapeutic capabilities. Management ...

Operationally, we grew PYLARIFY to over $1 billion in sales, making it the first ever radiodiagnostic blockbuster and the clear number one utilized PSA PET imaging agent. We also grew our market ...

Prostate imaging drug Pylarify has become the first radiodiagnostic blockbuster, achieving over $1 billion in sales for 2024. The addressable market continues to expand. We estimate [the addressable ...